{
    "key_points": [
        "Moderna and Pfizer are ramping up COVID-19 vaccine production, with Johnson & Johnson nearing emergency use authorization.",
        "As of a recent Wednesday, 14.5% of Coloradans have received at least one vaccine dose, with 6.8% fully vaccinated.",
        "Matt McQueen, CU Boulder's director of epidemiology, emphasizes vaccines' role in ending the pandemic.",
        "Pfizer and Moderna use mRNA technology for their vaccines, which instructs cells to produce a spike protein to trigger an immune response.",
        "The mRNA vaccines are deemed safe, having gone through rigorous FDA approval processes and post-approval safety monitoring.",
        "Side effects after vaccination are possible and generally indicate the immune system's active response.",
        "The vaccines are highly effective in preventing severe disease, hospitalization, and death due to COVID-19.",
        "There's early evidence suggesting vaccinated individuals, if infected, experience much milder illness.",
        "Existing vaccines appear to offer protection against new COVID-19 variants by preventing severe illness.",
        "Vaccinated individuals at CU Boulder must follow safety guidelines, but can relax precautions in fully vaccinated groups."
    ],
    "spokespersons": [
        "Matt McQueen (Director of Epidemiology, Pandemic Response Office, CU Boulder)"
    ],
    "article_type": "general reporting",
    "dateline": "",
    "audience": "general public",
    "stance": "neutral"
}